P
Plus Therapeutics D
D
PSTV
0.57900
USD
0.04
(7.22%)
قبل الجلسة
حجم التداول
100
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
29,528,113
الأخبار المقالات
العنوان: Plus Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).